About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

NCT04146051·15 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Cartesian Therapeutics

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patient must be at least 18 years of age.
Patient must have Generalized Myasthenia Gravis at the time of screening.
Concomitant immunosuppressive drugs must be deemed necessary by the investigator.
Seronegative Patients are included

You may not be if

Major chronic illness that is not well managed at the time of study entry and in the opinion of the investigator may increase the risk to the patient.
Patient is pregnant or lactating.

The record

StatusActive not recruiting

PhasePhase 2

Taking part30

StartedDec 2019

UpdatedAug 14, 2026

Conditions

Myasthenia Gravis, Generalized

Where15

Profound Research
Carlsbad, California, United States
University of California Irvine
Irvine, California, United States
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States